FDA.reportPublic FDA data

sufentanil 0.03 MG Sublingual Tablet

RxCUI
2103192
RxNorm name
sufentanil 0.03 MG Sublingual Tablet
Display name
sufentanil 0.03 MG Sublingual Tablet
Full name
sufentanil 0.03 MG Sublingual Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8b580f3d-e3b5-4086-b093-87a980631147SUFentanil 30 MCG Sublingual Tablet [PSN] · sufentanil 0.03 MG Sublingual Tablet [SCD] · sufentanil 30 MCG Sublingual Tablet [SY]38These highlights do not include all the information needed to use DSUVIA ® safely and effectively. See full prescribing information for DSUVIA ® . DSUVIA ® (sufentanil) sublingual tablet, CII Initial U.S. Approval: 198420251230